Poisoning by antivaric drugs, inc scler agents, undet, subs

This code signifies a poisoning event involving antivaricose medications, such as sclerosing agents, where the intent (accidental, intentional self-harm, assault, or undetermined) cannot be established. The "subsequent encounter" designation indicates that the patient is receiving follow-up care for the sequelae or complications of the initial poisoning, after the acute phase of treatment.

This code is appropriate for documenting ongoing management of a patient who previously experienced poisoning from antivaricose drugs, and the circumstances surrounding the poisoning remain unclear. This could include follow-up appointments for monitoring organ damage, managing persistent symptoms, or addressing long-term complications stemming from the initial exposure.

• Always assign an additional code for the specific manifestation of the poisoning, if known.
• Ensure documentation clearly supports the "undetermined" intent and the "subsequent encounter" status.
• Differentiate from initial encounters (A) or sequela encounters (S) based on the patient's current stage of care.